Though the pharma industry has improved its change management processes, there are still opportunities for improvement.
John Y. Lee
Advertisement
John Y. Lee is Executive Director (Former FDA Investigator) at Pharmaceutical Compliance Associates, US.
Articles by John Y. Lee
There are significant differences between the United States and European Union requirements for the annual review of records related to the manufacturing and control for pharmaceutical products and active pharmaceutical ingredients.
Advertisement
Latest Updated Articles
- Change management: common failures and a checklist for improvement
Published: May 1st 2010 | Updated:
- Product Annual/Quality Review: US–EU Comparative Analysis and Interpretations
Published: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
5
